![Gregory G. Mahairas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Gregory G.
Mahairas is President, Director & Chief Scientific Officer at BEAT BioTherapeutics Corp.
He is on the Board of Directors at BEAT BioTherapeutics Corp.
Dr. Mahairas was previously employed as Chief Technology Officer by VieVax Corp., a Director-High Throughput Sequencing Center by University of Washington, and Vice President-Operations by Regulome Corp.
| Companies | Position | End |
|---|---|---|
VieVax Corp.
 VieVax Corp. Medical/Nursing ServicesHealth Services Develops technology for genetic-based vaccines | Founder | 26/05/2010 |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
BEAT BioTherapeutics Corp.
 BEAT BioTherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapies for heart diseases | President | - |
Regulome Corp.
 Regulome Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Operating Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regulome Corp.
Regulome Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
VieVax Corp.
VieVax Corp. Medical/Nursing ServicesHealth Services Develops technology for genetic-based vaccines | Health Services |
BEAT BioTherapeutics Corp.
BEAT BioTherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapies for heart diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
